Memorizing these FPGEE Exam Cram is sufficient to pass the exam.

We are doing an extraordinary battle to offer you genuine Foreign Pharmacy Graduate Equivalency test questions and responses, alongside clarifications. Each FPGEE real questions on killexams.com has been checked and approved by our FPGEE specialists. They are qualified and confirmed individuals, who have a seriously long encounter seen with the Medical certificates. They really look at the FPGEE exam prep according to braindumps.

Exam Code: FPGEE Practice test 2022 by Killexams.com team
FPGEE Foreign Pharmacy Graduate Equivalency

The Foreign Pharmacy Graduate Equivalency Examination®, or FPGEE®, is one of the examinations required as part of the FPGEC Certification Program (You must also take and pass the TOEFL iBT, the English-language test administered by Educational Testing Service. Applications submitted after January 1, 2020 must complete the TOEFL iBT requirement prior to sitting for the FPGEE).

The FPGEE is offered once per year, and it is administered at Pearson VUE test sites throughout the continental United States. Only individuals made eligible during the FPGEC application process can take the FPGEE.

You will be notified via your e-Profile that you are eligible to sit for the FPGEE after successfully completing the FPGEC evaluation process. You must pass the FPGEE within two years of having your FPGEC application accepted or your application will expire, and you will need to submit a new FPGEC application.

An overview of FPGEC Certification
FPGEC and ECE application procedures
Documentation of pharmacist credentials
Registering for the FPGEE
FPGEE administration
FPGEE score results

The FPGEE Competency Statements provide a blueprint of the syllabus covered on the examination. A strong understanding of the Competency Statements will aid in your preparation to take the examination. The 200 questions on the FPGEE are divided among four content areas:

Basic biomedical sciences – 10%
Pharmaceutical sciences – 33%
Social, behavioral, administrative pharmacy sciences – 22%
Clinical sciences – 35%
The statements can be found in the FPGEC Candidate Application Bulletin.

Foreign Pharmacy Graduate Examination Committee™ (FPGEC®) Certification is required for foreign-educated pharmacists seeking to apply for the pharmacy licensing exams (including the North American Pharmacist Licensing Examination® (NAPLEX®) and Multistate Pharmacy Jurisprudence Examination® (MPJE®)) in the United States and NABP member jurisdictions. To obtain FPGEC Certification, a candidate must have their required documentation and application accepted, including a passing score on the Test of English as a Foreign Language Internet-based Test (TOEFL iBT), and pass the Foreign Pharmacy Graduate Equivalency Examination® (FPGEE®). The information below is provided to guide you through the key steps in applying for FPGEC Certification, including instructions for registering to take the FPGEE. It answers the most frequently asked questions about the FPGEC application process. Please read this information carefully and refer to the appropriate sections of this Application Bulletin for detailed information.

NABP provides the FPGEC Certification Program to document the educational equivalency of a candidates foreign pharmacy education, as well as their license and/or registration to practice pharmacy. To achieve FPGEC Certification, candidates must:
• Provide documents that verify their education background.
• Provide documents that verify licensure and/or registration to practice pharmacy.
• Pass the Test of English as a Foreign Language Internet-based Test (iBT).
• Pass the FPGEE.
Candidates who receive an FPGEC Certificate may be qualified to take the pharmacy licensing examination in jurisdictions that accept this Certification. All 50 US states, the District of Columbia, Guam, and Puerto Rico require foreign-trained pharmacists to achieve FPGEC Certification before applying for a license from a state board of pharmacy

- Physiology
- Function of the major body systems and homeostatic impact at organ and system level
- Biochemistry
- Chemistry and utilization of biomacromolecules including proteins, lipids, carbohydrates, nucleic acid, intermediary metabolism of energy and nutritional molecules
- Enzymology and coenzymes and kinetics
- Cell chemistry, signal transduction pathways
- Transport and mobility
- Recombinant DNA and molecular biotechnology
- mRNA translation and protein synthesis
- Microbiology Related to Human Disease
- Structure, function, and characteristics of microorganisms: microbe classification, structure, metabolism, genetics
- Pathogenic microorganisms of humans
- Immunology
- Innate and adaptive immunity
- Principles of antibody actions
- Hypersensitivity and types of reactions

Area 2.0 - Pharmaceutical Sciences (Approximately 33% of Test)
- Medicinal Chemistry
- Physicochemical properties of drugs in relation to drug absorption, distribution, metabolism, and excretion (ADME)
- Chemical basis for drug action
- Fundamental pharmacophores for drugs used to treat diseases
- Structure-activity relationships in relation to drug-target interactions
- Chemical pathways of drug metabolism
- Applicability to making drug therapy decisions
- Pharmacology and Toxicology
- Mechanisms of action of drugs of various categories including biologics
- Pharmacodynamics of drug binding and response
- Adverse effects and side effects of drugs
- Mechanisms of drug-drug interactions
- Drug discovery and development
- Acute and chronic toxic effect of xenobiotics, including drug and chemical overdose and antidotes
- Pharmacognosy and Dietary Supplements
- Concepts of crude drugs, semi-purified, and purified natural products
- Classes of pharmacologically active natural products
- Science and regulation of dietary supplements (vitamins, minerals, and herbals)
- Pharmaceutics/Biopharmaceutics
- Biopharmaceutical principles of drug delivery to the body via dosage forms: liquid, solid, semisolid, controlled release, patches, implants
- Materials and methods used in preparation of drug forms
- Physicochemical properties relating to drug entities and dosage forms
- Principles of drug and dosage form stability, including chemical degradation and physical instability
- Pharmacokinetics
- Basic principles of in-vivo drug kinetics (linear and nonlinear)
- Principles of bioavailability and bioequivalence
- Physiologic determinates of drug onset and duration, including disease and dietary influences on absorption, distribution, metabolism, and excretion
- Pharmacogenomics and Genetics
- Molecular genetics, genomic, proteomic, and metabolomic principles that serve as a foundation for pharmacogenomics and the genetic basis of disease
- Genetic variants affecting drug action and metabolism, adverse drug reactions, and disease risk that influence the practice of personalized medicine
- Sterile and Nonsterile Compounding
- United States Pharmacopeia guidelines on sterile and nonsterile compounding, hazardous drugs, and FDA regulation of compounding
- Techniques and principles used to prepare and dispense individual extemporaneous prescriptions, including dating of compounded dosage forms
- Dosage form preparation calculations
- Sterile admixture techniques, including stability, clean-room requirements, sterility testing, and dating

Area 3.0 – Social/Behavioral/Administrative Sciences (Approximately 22% of Test)
- Health Care Delivery Systems and Public Health
- Organization of health care delivery systems at the national, state, and local levels: various settings where pharmacy is practiced and the structure of health care delivery systems such as managed care organizations, accountable care organizations, health departments
- Health care delivery financing in the United States
- Social, political, and economic factors that influence the delivery of health care in the United States
- Public Health and Wellness: chronic disease prevention, health promotion, infectious disease control, demographics, physical, social, and environmental factors leading to disease, comparing and contrasting public health with individual medical care
- The health care delivery system compared and contrasted with that of other industrialized nations
- Population-Based Care and Pharmacoepidemiology
- Data sources and analytic tools that provide an estimate of the probability of beneficial or adverse effects of medication use in large populations
- Application of epidemiological study designs to evaluate drug use and outcomes in large populations
- Methods for continually monitoring unwanted effects and other safety-related aspects of medication use in large populations
- Economic and Humanistic Outcomes of Health Care Delivery
- General microeconomic and general macroeconomic principles
- Pharmacoeconomic analysis and its application to Improve the allocation of limited health care resources
- Humanistic outcomes and their application to Improve the allocation of limited health care resources
- Pharmacy Practice Management
- Management principles (planning, organizing, directing, and controlling pharmacy resources) applied to various pharmacy practice setting and patient outcomes
- Personnel management
- Planning, including delineation between business and strategic planning
- Marketing of goods and services: product versus service pricing, distribution, promotion
- Accounting and financial management
- Budgeting
- Risk management
- Pharmacy Law and Regulatory Affairs
- Legal and regulatory principles applied to pharmacy practice: dispensing, professional services, drug use control
- Administrative, civil, and criminal liability
- Authority, responsibilities, and operation of agencies and entities that promulgate or administer laws, regulations, or guidances related to practice and prescription and nonprescription medications
- Biostatistics and Research Design
- Research study designs used in medical research
- Application and interpretation of statistical tests and data collection instruments
- Ethical Decision Making
- Principles of biomedical ethics
- Ethical dilemmas in the delivery of patient-centered care including, conflicts of interest, end-of-life decision making, use of codes of ethics, oaths of the pharmacist
- Research ethics
- Professional Communication
- Communication abilities (appropriate verbal, nonverbal, visual, and written) with patient and caregivers, including empathetic communication
- Communication abilities with other health care providers
- Assertiveness and problem-solving techniques in relation to difficult social and professional conflicts and situations
- Measurement and use of health literacy in pharmacy communications
- Development of cultural competency in pharmacy personnel such that services are respectful of and responsive to the health beliefs, practices, and cultural and linguistic needs of diverse patient populations
- Social and Behavioral Aspects of Pharmacy Practice
- Health-, illness-, and sick-role behaviors of patients
- Principles of behavior modification
- Patient adherence to therapies and recommendations
- Caregiving throughout the lifecycle
- Death and dying
- Medication Dispensing and Distribution Systems
- Systems for safe and effective preparation and dispensing of medications in all types of practice settings
- Role of automation and technology: pharmacy informatics, information management
- Continuous quality improvement programs or protocols in the medication-use process, including identification and prevention of medication errors, and establishment of error reduction programs

Area 4.0 – Clinical Sciences (Approximately 35% of Test)
- Evidence-based Practice
- Interpret and evaluate drug information
- Apply drug-information skills for the delivery of medication therapy management
- Evaluate the reliability of various sources of information
- Interpret guidelines as they apply in a clinical setting
- Utilize core scientific and systems-based knowledge in the patient care decision-making process
- Utilize basic science principles in the development and/or implementation of drug treatment protocols and clinical practice guidelines
- Evaluate clinical trials that validate clinical appropriateness
- Clinical Pathophysiology
- Apply concepts of pathophysiology to clinical decision making
- Clinical Pharmacokinetics
- Utilize pharmacokinetics to calculate, evaluate, and individualize drug therapy
- Interpret clinical pharmacokinetics of commonly used and low-therapeutic-index drug
s - Clinical Pharmacogenomics
- Utilize pharmacogenomics to calculate, evaluate, and individualize drug therapy
- Disease Prevention and Population Health
- Recognize the proper use of nonpharmacologic therapies, including complementary and alternative medicines
- Describe measures to promote wellness and disease prevention
- Identify the role of immunizations in disease prevention and health promotion
- Patient Assessment
- Describe techniques for obtaining a comprehensive patient history
- Describe how to perform patient physical assessments: inspection, palpation, percussion, auscultation
- Differentiate between normal physical assessment findings and modifications caused by common disease states and drug therapy
- Interpret common clinical laboratory values and diagnostic tests
- Perform calculations related to patient assessment: BMI, CrCl, lab adjustments
- Describe the use of OTC point-of-care testing devices: glucometers, pregnancy tests, home testing for HbA1c, drug screening
- Clinical Pharmacology and Therapeutic Decision Making
- Make therapy recommendations based on dosage calculations, specific uses and indications of drugs and nutritional and support therapy
- Interpret therapeutic drug concentrations
- Assess pharmacotherapy considering contraindications, therapeutic duplications, dietary interactions, adverse drug reactions and interactions, and allergies
- Triage and identify when to refer patients to other health professionals
- Design patient-centered, culturally-relevant treatment plans
- Apply evidence-based decision making to patient care
- Recommend nonprescription and natural product therapies
- Identify and manage drug toxicity, drug-induced diseases, and misuse or abuse
- Monitor drug therapy for misuse, abuse, and non-adherence

Foreign Pharmacy Graduate Equivalency
Medical Equivalency test contents
Killexams : Medical Equivalency test contents - BingNews https://killexams.com/pass4sure/exam-detail/FPGEE Search results Killexams : Medical Equivalency test contents - BingNews https://killexams.com/pass4sure/exam-detail/FPGEE https://killexams.com/exam_list/Medical Killexams : The American Board of Medical Specialties Response to National Board of Physicians and Surgeons’ Assertion Of Certifying Body Equivalency

Press release content from PR Newswire. The AP news staff was not involved in its creation.

CHICAGO, July 29, 2022 /PRNewswire/ -- The American Board of Medical Specialties (ABMS) strongly disagrees with the persistent and misleading assertions that the National Board of Physicians and Surgeons (NBPAS) recertification process provides a means of continuing ABMS board certification or is equivalent to ABMS board certification. Claims of equivalence to ABMS certification or that NBPAS is a means to maintain ABMS Member Board certification are misleading to the profession, and most importantly, to the public who depend upon the strength of ABMS board certification.

Unlike the ABMS Member Boards, NBPAS does not have a process for defining specialty specific standards for knowledge. It does not offer an external assessment of knowledge and skills, which the Institute for Credentialing Excellence defines as the essence of a certification program’s ability to validate competence, nor is the NBPAS certificate consistent with established American Medical Association policy on certification.

NBPAS does not have a requirement for improving medical practice, nor does it appear to have a means to address unprofessional conduct by its members. Lastly, it does not engage in research to provide the evidence base supporting the value of its program and informing its continued quality improvement.

ABMS and its Member Boards recently completed a comprehensive, transparent and collaborative process to review and enhance the Member Boards’ continuing certification programs, ensuring they are both relevant and supportive of diplomates’ learning and improvement needs while providing the public with a reliable and dependable credential. These program revisions address concerns that had been expressed by diplomates about continuing certification: they offer an alternative to the high-stakes exams, provide feedback to support learning, and include processes to allow diplomates to meet requirements prior to certificate loss.

All of these changes serve to reduce diplomate costs, and diplomates like them: Ninety-eight percent of surveyed diplomates prefer longitudinal assessment models over the previous high-stakes exam. At the same time, ABMS continuing certification continues to honor its obligation to the public to verify that ABMS Board Certified physicians have demonstrated the knowledge, skills, and professionalism to provide high quality specialty care.

The value of board certification should not be understated. Patients deserve access to highly skilled specialty care. They expect their physicians to be up to date with the most exact medical advances in their specialties and to demonstrate their proficiency through a rigorous Board certification process. Recognizing NBPAS as a certifying body equivalent to ABMS Member Boards will confuse the public and the profession regarding the meaning and purpose of board certification and may undermine the public trust in board certification and professional self-regulation.

View original content to download multimedia: https://www.prnewswire.com/news-releases/the-american-board-of-medical-specialties-response-to-national-board-of-physicians-and-surgeons-assertion-of-certifying-body-equivalency-301596420.html

SOURCE American Board of Medical Specialties

Fri, 29 Jul 2022 11:15:00 -0500 en text/html https://apnews.com/press-release/pr-newswire/a4605d3970703495c44a4d2f882bfea8
Killexams : The American Board of Medical Specialties Response to National Board of Physicians and Surgeons' Assertion Of Certifying Body Equivalency The American Board of Medical Specialties Response to National Board of Physicians and Surgeons' Assertion Of Certifying Body Equivalency

PR Newswire

CHICAGO, July 29, 2022

CHICAGO, July 29, 2022 /PRNewswire/ -- The American Board of Medical Specialties (ABMS) strongly disagrees with the persistent and misleading assertions that the National Board of Physicians and Surgeons (NBPAS) recertification process provides a means of continuing ABMS board certification or is equivalent to ABMS board certification. Claims of equivalence to ABMS certification or that NBPAS is a means to maintain ABMS Member Board certification are misleading to the profession, and most importantly, to the public who depend upon the strength of ABMS board certification.

Unlike the ABMS Member Boards, NBPAS does not have a process for defining specialty specific standards for knowledge. It does not offer an external assessment of knowledge and skills, which the Institute for Credentialing Excellence defines as the essence of a certification program's ability to validate competence, nor is the NBPAS certificate consistent with established American Medical Association policy on certification.

NBPAS does not have a requirement for improving medical practice, nor does it appear to have a means to address unprofessional conduct by its members. Lastly, it does not engage in research to provide the evidence base supporting the value of its program and informing its continued quality improvement.

ABMS and its Member Boards recently completed a comprehensive, transparent and collaborative process to review and enhance the Member Boards' continuing certification programs, ensuring they are both relevant and supportive of diplomates' learning and improvement needs while providing the public with a reliable and dependable credential. These program revisions address concerns that had been expressed by diplomates about continuing certification: they offer an alternative to the high-stakes exams, provide feedback to support learning, and include processes to allow diplomates to meet requirements prior to certificate loss.

All of these changes serve to reduce diplomate costs, and diplomates like them: Ninety-eight percent of surveyed diplomates prefer longitudinal assessment models over the previous high-stakes exam. At the same time, ABMS continuing certification continues to honor its obligation to the public to verify that ABMS Board Certified physicians have demonstrated the knowledge, skills, and professionalism to provide high quality specialty care.

The value of board certification should not be understated. Patients deserve access to highly skilled specialty care. They expect their physicians to be up to date with the most exact medical advances in their specialties and to demonstrate their proficiency through a rigorous Board certification process. Recognizing NBPAS as a certifying body equivalent to ABMS Member Boards will confuse the public and the profession regarding the meaning and purpose of board certification and may undermine the public trust in board certification and professional self-regulation.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-american-board-of-medical-specialties-response-to-national-board-of-physicians-and-surgeons-assertion-of-certifying-body-equivalency-301596420.html

SOURCE American Board of Medical Specialties

Fri, 29 Jul 2022 11:54:00 -0500 en text/html https://www.morningstar.com/news/pr-newswire/20220729dc31792/the-american-board-of-medical-specialties-response-to-national-board-of-physicians-and-surgeons-assertion-of-certifying-body-equivalency
Killexams : The American Board of Medical Specialties Response to National Board of Physicians and Surgeons' Assertion Of Certifying Body Equivalency

CHICAGO, July 29, 2022 /PRNewswire/ -- The American Board of Medical Specialties (ABMS) strongly disagrees with the persistent and misleading assertions that the National Board of Physicians and Surgeons (NBPAS) recertification process provides a means of continuing ABMS board certification or is equivalent to ABMS board certification. Claims of equivalence to ABMS certification or that NBPAS is a means to maintain ABMS Member Board certification are misleading to the profession, and most importantly, to the public who depend upon the strength of ABMS board certification.

Unlike the ABMS Member Boards, NBPAS does not have a process for defining specialty specific standards for knowledge. It does not offer an external assessment of knowledge and skills, which the Institute for Credentialing Excellence defines as the essence of a certification program's ability to validate competence, nor is the NBPAS certificate consistent with established American Medical Association policy on certification.

NBPAS does not have a requirement for improving medical practice, nor does it appear to have a means to address unprofessional conduct by its members. Lastly, it does not engage in research to provide the evidence base supporting the value of its program and informing its continued quality improvement.

ABMS and its Member Boards recently completed a comprehensive, transparent and collaborative process to review and enhance the Member Boards' continuing certification programs, ensuring they are both relevant and supportive of diplomates' learning and improvement needs while providing the public with a reliable and dependable credential. These program revisions address concerns that had been expressed by diplomates about continuing certification: they offer an alternative to the high-stakes exams, provide feedback to support learning, and include processes to allow diplomates to meet requirements prior to certificate loss.

All of these changes serve to reduce diplomate costs, and diplomates like them: Ninety-eight percent of surveyed diplomates prefer longitudinal assessment models over the previous high-stakes exam. At the same time, ABMS continuing certification continues to honor its obligation to the public to verify that ABMS Board Certified physicians have demonstrated the knowledge, skills, and professionalism to provide high quality specialty care.

The value of board certification should not be understated. Patients deserve access to highly skilled specialty care. They expect their physicians to be up to date with the most exact medical advances in their specialties and to demonstrate their proficiency through a rigorous Board certification process. Recognizing NBPAS as a certifying body equivalent to ABMS Member Boards will confuse the public and the profession regarding the meaning and purpose of board certification and may undermine the public trust in board certification and professional self-regulation.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-american-board-of-medical-specialties-response-to-national-board-of-physicians-and-surgeons-assertion-of-certifying-body-equivalency-301596420.html

SOURCE American Board of Medical Specialties

Fri, 29 Jul 2022 12:30:00 -0500 en-US text/html https://fox40.com/business/press-releases/cision/20220729DC31792/the-american-board-of-medical-specialties-response-to-national-board-of-physicians-and-surgeons-assertion-of-certifying-body-equivalency/
FPGEE exam dump and training guide direct download
Training Exams List